drug

cyclosporine

1 story · latest Aug 6, 2026

Status: FDA approved Nov 1983 · NDA021023, NDA050573, NDA050574, NDA050625, NDA050715, NDA050716, NDA050735, NDA050736, NDA050737, NDA050738, NDA050790, NDA210913, NDA214965
Brands: Cequa, Neoral, Restasis, Restasis Multidose, Sandimmune, Verkazia

Relationships

Developed by AbbVie

Developed by Novartis

Developed by Harrow Inc

Developed by Sun Pharmaceutical Industries

Timeline

Harrow to acquire global rights to TYRVAYA nasal spray from Viatris

Aug 6Regulatory decisioncyclosporine ophthalmic solution Harrow Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.